Oncologists' attitudes toward KRAS testing: a multisite study.
about
Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review.A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients.Advanced cancer patients' attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study.KRAS biomarker testing disparities in colorectal cancer patients in New Mexico.
P2860
Oncologists' attitudes toward KRAS testing: a multisite study.
description
2013 թվականի հոկտեմբերի 2-ին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Oncologists' attitudes toward KRAS testing: a multisite study.
@en
Oncologists' attitudes toward KRAS testing: a multisite study.
@nl
type
label
Oncologists' attitudes toward KRAS testing: a multisite study.
@en
Oncologists' attitudes toward KRAS testing: a multisite study.
@nl
prefLabel
Oncologists' attitudes toward KRAS testing: a multisite study.
@en
Oncologists' attitudes toward KRAS testing: a multisite study.
@nl
P2093
P2860
P356
P1433
P1476
Oncologists' attitudes toward KRAS testing: a multisite study.
@en
P2093
Alanna Rahm
Andrew Williams
Carol P Somkin
Gwen L Alexander
Julie N Harris
Katrina A B Goddard
Pamala Pawloski
Petra Liljestrand
Suzanne O'Neill
Tatjana Kolevska
P2860
P304
P356
10.1002/CAM4.135
P407
P577
2013-10-02T00:00:00Z